Filters

Latest News

2020-07-26 18:16:22

WADA and IFPMA strengthen collaboration in the protection of clean sport

Geneva / Montreal, 28 July 2020: The World Anti-Doping Agency (WADA) and the International Federation of Pharmaceutical Manufacturers and Associations ...

Read More

2020-07-09 13:30:55

New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion

New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment ...

Read More

2020-06-08 07:54:23

Global Pharma Body Names New Communications Director

Geneva, 8 June, 2020: The industry body representing research-based biopharmaceutical companies and regional and national ...

Read More

2020-06-04 13:02:10

Pharma pledges to continue 20 year partnership with Gavi, the Vaccine Alliance

IFPMA members have worked for 20 years with Gavi to stem the ravages of childhood ...

Read More

2020-05-28 15:00:58

Pharma partners in efforts to give coronavirus vaccine for everyone

Geneva, 28 May 2020. IFPMA has today updated the world’s media on the biopharmaceutical industry’s ...

Read More

2020-05-28 08:04:20

Pharma industry updates advice on engaging with healthcare professionals as countries emerge from COVID-19 lockdown

Geneva, 28 May 2020: As countries lift lockdown restrictions, the international pharma industry body, IFPMA, ...

Read More

2020-05-19 15:31:26

Pharma and other innovative health groups tell World Health Assembly it stands united with governments and global health stakeholders worldwide to combat COVID-19

Geneva, May 19, 2020: At the Seventy-Third World Health Assembly, IFPMA, the industry body representing ...

Read More

Latest Statement

2020-06-26 10:12:47

IFPMA Statement - Access to COVID-19 Tools Accelerator (ACT-Accelerator) Investment Case

Geneva, 26 June 2020: Today, we face the first global pandemic in living memory; affecting hundreds of millions of people ...

Read More

2020-06-04 13:01:49

Biopharmaceutical Industry Statement at Gavi, the Vaccine Alliance – Global Vaccine Summit 2020

Geneva, May 19, 2020: At the Seventy-Third World Health Assembly, ...

Read More

2020-05-28 19:14:41

IFPMA Statement on the “Solidarity Call to Action to realize equitable global access to COVID-19 health technologies through pooling of knowledge, intellectual property and data”

Geneva, May 19, 2020: At the Seventy-Third World Health Assembly, ...

Read More

2020-05-18 08:01:23

Joint Statement – Innovative Health Industries @ WHA73

Geneva, May 19, 2020: At the Seventy-Third World Health Assembly, ...

Read More

2020-05-04 16:23:13

Pharma Statement for The Coronavirus Global Response Pledging Marathon

Geneva, May 19, 2020: At the Seventy-Third World Health Assembly, ...

Read More

2020-04-24 13:41:50

IFPMA Statement on the launch of a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools

Geneva, May 19, 2020: At the Seventy-Third World Health Assembly, ...

Read More

2020-04-21 09:01:40

Innovative health industries united in welcoming United Nations General Assembly Resolution on “International Cooperation to ensure global access to medicines, vaccines and medical equipment to face COVID-19"

Geneva, May 19, 2020: At the Seventy-Third World Health Assembly, ...

Read More

mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig

Sadia Kaenzig - Communications Manager

Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.

mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol

Morgane De Pol - Communications and Public Affairs

Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

Hot Topic

Pharmacovigilance: Do your bit, play your part!

Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is

Read More

Interview

IFPMA 2015 interview series 'Biodiversity, human health, and pharma'

A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to

Read More

Our Blog

Latest Tweets

The onset of #COVID19 has devastated #immunization programs, leaving huge number of children unprotected from deadl… https://t.co/k6CKZbpcnl
1
Vaccines typically take years, if not decades, to reach people. @DrewQJoseph explains what has propelled efforts on… https://t.co/dYA3pB5ptG
Great discussion on challenges around #COVID19 vaccines. One key message is around maintaining high levels of publi… https://t.co/tHTCsf6SHG
1
Trust is at the heart of the @IFPMA Ethos, helping us foster a culture grounded in integrity, values and principles… https://t.co/piqXrj9o7V
2